Afagh Garjani

812 total citations
42 papers, 517 citations indexed

About

Afagh Garjani is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Afagh Garjani has authored 42 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pathology and Forensic Medicine, 12 papers in Molecular Biology and 12 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Afagh Garjani's work include Cardiac Ischemia and Reperfusion (10 papers), Multiple Sclerosis Research Studies (8 papers) and Cardiac electrophysiology and arrhythmias (4 papers). Afagh Garjani is often cited by papers focused on Cardiac Ischemia and Reperfusion (10 papers), Multiple Sclerosis Research Studies (8 papers) and Cardiac electrophysiology and arrhythmias (4 papers). Afagh Garjani collaborates with scholars based in Iran, United Kingdom and United States. Afagh Garjani's co-authors include Nasrin Maleki‐Dizaji, Hamid Soraya, Alireza Garjani, Arash Khorrami, Nikos Evangelou, Cherry L. Wainwright, C. W. M. Wilson, Sina Andalib, I. J. Zeitlin and Manouchehr Khoshbaten and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Neurology Neurosurgery & Psychiatry and European Journal of Pharmacology.

In The Last Decade

Afagh Garjani

41 papers receiving 494 citations

Peers

Afagh Garjani

PFM

CCM

PHYSI

IMMUN

Wen-Chih Liu Taiwan

Najah R. Hadi Iraq

Bram Ramjiawan Canada

Fabio Infusino Italy

Ana I. Perez‐Caballero Spain

Maria Tsoumani Greece

Yong-Wha Lee South Korea

Kiyan Heshmat‐Ghahdarijani Iran

Tahereh Safari Iran

Mina Kelleni Egypt

Wen-Chih Liu Taiwan

Afagh Garjani

267 ×1.6

186 ×1.2

PFM

61 ×0.5

CCM

111 ×1.5

PHYSI

52 ×1.0

IMMUN

Citations per year, relative to Afagh Garjani Afagh Garjani (= 1×) peers Wen-Chih Liu

Countries citing papers authored by Afagh Garjani

Since Specialization

Citations

This map shows the geographic impact of Afagh Garjani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Afagh Garjani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Afagh Garjani more than expected).

Fields of papers citing papers by Afagh Garjani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Afagh Garjani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Afagh Garjani. The network helps show where Afagh Garjani may publish in the future.

Co-authorship network of co-authors of Afagh Garjani

This figure shows the co-authorship network connecting the top 25 collaborators of Afagh Garjani. A scholar is included among the top collaborators of Afagh Garjani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Afagh Garjani. Afagh Garjani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Garjani, Afagh, et al.. (2025). Medication use is associated with cognitive deficits in people with multiple sclerosis. Multiple Sclerosis and Related Disorders. 97. 106386–106386.

Garjani, Afagh, et al.. (2024). Real-world data on siponimod-related lymphopenia among people with secondary progressive multiple sclerosis. Multiple Sclerosis Journal. 30(4-5). 600–604. 1 indexed citations

Shayanfar, Ali, et al.. (2024). Implementation of an integrated pharmacy education system for pharmacy students: a controlled educational trial. BMC Medical Education. 24(1). 1272–1272. 3 indexed citations

Garjani, Afagh, Christopher Allen, Douglas Gunzler, et al.. (2022). Decentralised clinical trials in multiple sclerosis research. Multiple Sclerosis Journal. 29(3). 317–325. 4 indexed citations

Garjani, Afagh, Rachael Hunter, Graham Law, et al.. (2021). Mental health of people with multiple sclerosis during the COVID-19 outbreak: A prospective cohort and cross-sectional case–control study of the UK MS Register. Multiple Sclerosis Journal. 28(7). 1060–1071. 20 indexed citations

Garjani, Afagh, Rod Middleton, Rachael Hunter, et al.. (2021). COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapies. Multiple Sclerosis and Related Disorders. 52. 102939–102939. 36 indexed citations

Nair, Roshan das, Rachael Hunter, Afagh Garjani, et al.. (2021). Challenges of developing, conducting, analysing and reporting a COVID-19 study as the COVID-19 pandemic unfolds: an online co-autoethnographic study. BMJ Open. 11(6). e048788–e048788. 4 indexed citations

Maleki‐Dizaji, Nasrin, et al.. (2021). Time-dependent influence of infliximab on hemodynamic responses and cardiac injuries of isoproterenol-induced myocardial infarction in rats. European Journal of Pharmacology. 903. 174122–174122. 9 indexed citations

Ghaffari, Samad, et al.. (2020). Oxidative stress and its association with ST resolution and clinical outcome measures in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention. BMC Research Notes. 13(1). 525–525. 11 indexed citations

10.

Abbaszadeh, Samin, et al.. (2019). Hydroalcoholic Extract from Rhizomes of Cynodon dactylon Improve Hemodynamic and Electrocardiogram Parameters in Myocardial Infarction in Rats. Pharmaceutical Sciences. 25(3). 198–204. 1 indexed citations

11.

Bagheri, Bahador, Afagh Garjani, Bahram Sohrabi, et al.. (2015). Everolimus-Eluting Stents Reduce Monocyte Expression of Toll-Like Receptor 4. Advanced Pharmaceutical Bulletin. 5(Suppl 1). 643–647. 3 indexed citations

12.

Garjani, Afagh, et al.. (2015). Association Between Platelet Count as a Noninvasive Marker and Ultrasonographic Grading in Patients With Nonalcoholic Fatty Liver Disease. Hepatitis Monthly. 15(1). e24449–e24449. 24 indexed citations

13.

Maleki‐Dizaji, Nasrin, et al.. (2012). Anti-inflammatory effects of clavulanic acid in carrageenan induced paw edema in rats. Research in Pharmaceutical Sciences. 7(5). 957. 1 indexed citations

14.

Azarmi, Yadollah, et al.. (2012). Study the effects of metformin on renal function and structure after unilateral ischemia-reperfusion in rat. Research in Pharmaceutical Sciences. 7(5). 77. 16 indexed citations

15.

Soraya, Hamid, et al.. (2012). Acute treatment with metformin improves cardiac function following isoproterenol induced myocardial infarction in rats. Pharmacological Reports. 64(6). 1476–1484. 78 indexed citations

16.

Garjani, Alireza, et al.. (2011). Combined atorvastatin and coenzyme Q10 improve the left ventricular function in isoproterenol-induced heart failure in rat. European Journal of Pharmacology. 666(1-3). 135–141. 51 indexed citations

17.

Garjani, Afagh, et al.. (2009). The Effect of Interactive Group Discussion among Physicians to Promote Rational use of Drugs. SHILAP Revista de lepidopterología. 2 indexed citations

18.

Najafi, Moslem, et al.. (2007). EFFECTS OF L-CARNITINE ON CARDIAC APOPTOSIS IN ISCHEMIC- REPERFUSED ISOLATED RAT HEART. Iranian journal of pharmaceutical sciences. 3(1). 19–24. 2 indexed citations

19.

Zeitlin, I. J., Graeme A. Deuchar, Maqsood Ahmad, David G. Campbell, & Afagh Garjani. (1996). Modulation of kinin outflow from isolated perfused rat hearts by endothelin-1. Immunopharmacology. 33(1-3). 294–296. 1 indexed citations

20.

Garjani, Afagh, et al.. (1995). Effects of Endothelin-1 and the ETA-Receptor Antagonist, BQ123, on Ischemic Arrhythmias in Anesthetized Rats. Journal of Cardiovascular Pharmacology. 25(4). 634–642. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact